Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 09 Jun 2024 04:13:52 +0200Fri, 19 Apr 2024 17:37:00 +0200Cyramza : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-2829-en.pdfCyramza : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-2829-en.pdfFri, 19 Apr 2024 17:37:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 17, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/cyramzaHuman medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 17, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/cyramzaFri, 19 Apr 2024 15:30:02 +0200Human medicine